AVITA MEDICAL AMERICAS, LLC

AVITA MEDICAL AMERICAS, LLC specializes in the development and manufacturing of advanced autograft-sparing medical devices for burn wound care, with a focus on regenerative tissue technologies. Their core capabilities center on the design, production, and clinical deployment of autologous skin cell harvesting and delivery systems, particularly the RECELL® system, which enables point-of-care processing of patient-derived keratinocytes and melanocytes for definitive burn wound repair. Technical expertise includes minimally invasive tissue harvesting, cell suspension formulation, sterile bioprocessing, and FDA-regulated medical device manufacturing under current Good Manufacturing Practices. The company’s key differentiator lies in its proprietary technology that preserves viable autologous cells while minimizing donor site morbidity, offering a clinically superior alternative to traditional skin grafting. The contractor has delivered solutions to both the Department of Defense and the Department of Health and Human Services, demonstrating a proven ability to support military trauma care and civilian burn center applications. For DoD, they provide battlefield-ready regenerative medical systems tailored for expeditionary care; for HHS, they support research and development of next-generation autograft-sparing therapies for acute and chronic wound management. Their primary industry focus is surgical and medical instrument manufacturing, specifically in the niche of regenerative medicine devices, alongside targeted biotechnology R&D for dermatological and trauma applications. This positions them as a specialized player in the advanced wound care market, serving both clinical and defense medical communities with innovation-driven, patient-specific solutions. AVITA MEDICAL AMERICAS, LLC is a limited liability entity headquartered in Valencia, California, with no federal certifications on record. Their operational footprint is centered on U.S.-based manufacturing and R&D, with a strategic government market presence focused on trauma care and regenerative health initiatives.